The Lancet Gastroenterology and Hepatology
The Lancet Gastroenterology and Hepatology is a journal indexed in SJR in Gastroenterology and Hepatology with an H index of 123. It has an SJR impact factor of 11,398 and it has a best quartile of Q1. It has an SJR impact factor of 11,398.
The Lancet Gastroenterology and Hepatology focuses its scope in these topics and keywords: gastrointestinal, hepatitis, multicentre, bowel, chronic, activity, exploration, magnetic, relapsed, cessation, ...
Metrics
Scimago and CountryOfPapers database fields
SJR Impact
11,398
H-index
123
Docs (year)
242
Docs 3y
682
Total refs
5228
Cites 3y
8156
Citable 3y
245
Cites/Doc 2y
13.01
Ref/Doc
21.6
Immediate OA
—
Embargoed OA
NPD
Non OA / Submission
—
Name good journals. Call out predatory ones.
Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.
Researcher reviews
Best articles by citations
Can artificial intelligence standardise colonoscopy quality?
View moreWatch-and-wait strategy in rectal cancer -Authors' reply
View moreDirect-acting antivirals for chronic hepatitis C virus genotype 5 and 6 infections
View moreDiagnostic accuracy of MRE and ultrasound for Crohn's disease -Authors' reply
View moreDiagnostic accuracy of MRE and ultrasound for Crohn's disease
View moreDetection of colorectal adenomas with a real-time computer-aided system (ENDOANGEL): a randomised controlled study
View moreDeep learning for colorectal polyp detection: time for clinical implementation?
View moreDecision making for liver biopsy in NASH, not so FAST?
View moreCytosponge use in risk stratification of Barrett's oesophagus
View moreColon cancer in Asian patients with ulcerative colitis
View moreCivil society's critical role in the elimination of viral hepatitis
View moreChronic hepatitis C: less of a problem than first thought?
View moreCartoons for paediatric patients
View more15th European Crohn's and Colitis Organisation Congress
View moreBursectomy versus omentectomy alone for resectable gastric cancer (JCOG1001): a phase 3, open-label, randomised controlled trial
View moreBowel cancer diagnostic services in the UK: at full capacity?
View moreBodily Functions and Where to Find Them: comedy with a serious message
View moreBeyond the Milan criteria for liver transplantation in children with hepatic tumours
View moreAssessment of small bowel mucosal healing by video capsule endoscopy for the prediction of short-term and long-term risk of Crohn's disease flare: a prospective cohort study
View moreASCO 2020 Gastrointestinal Cancers Symposium
View moreApps: solutions to sociological and health problems
View moreAnti-TNF treatment failure: drug levels, immunogenicity, or both?
View moreAccelerating the elimination of viral hepatitis for Indigenous peoples
View moreA watershed moment in tackling childhood obesity
View more